###begin article-title 0
###xml 98 102 <span type="species:ncbi:10090">Mice</span>
Weak Proinsulin Peptide-Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
###end article-title 0
###begin p 1
###xml 43 64 43 64 <email xmlns:xlink="http://www.w3.org/1999/xlink">mleviset@im.wustl.edu</email>
Corresponding author: Matteo G. Levisetti, mleviset@im.wustl.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Weak major histocompatibility complex (MHC) binding of self-peptides has been proposed as a mechanism that may contribute to autoimmunity by allowing for escape of autoreactive T-cells from the thymus. We examined the relationship between the MHC-binding characteristics of a beta-cell antigen epitope and T-cell autoreactivity in a model of autoimmune diabetes.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7+</sup>
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k+</sup>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-The binding of a proinsulin epitope, proinsulin-1(47-64) (PI-1[47-64]), to the MHC class II molecules I-Ag7 and I-Ak was measured using purified class II molecules. T-cell reactivity to the proinsulin epitope was examined in I-Ag7+ and I-Ak+ mice.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
RESULTS-C-peptide epitopes bound very weakly to I-Ag7 molecules. However, C-peptide-reactive T-cells were induced after immunization in I-Ag7-bearing mice (NOD and B6.g7) but not in I-Ak-bearing mice (B10.BR and NOD.h4). T-cells reactive with the PI-1(47-64) peptide were found spontaneously in the peripancreatic lymph nodes of pre-diabetic NOD mice. These T-cells were activated by freshly isolated beta-cells in the presence of antigen-presenting cells and caused diabetes when transferred into NOD.scid mice.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-These data demonstrate an inverse relationship between self-peptide-MHC binding and T-cell autoreactivity for the PI-1(47-64) epitope in autoimmune diabetes.
###end p 6
###begin p 7
Published ahead of print at  on 8 April 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 32 36 32 36 <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" vol="57" page="1788" id="N0x1c78f90N0x1ef7e30" xlink:href="18586912" ext-link-type="pubmed">1788</related-article>
See accompanying commentary, p. 1788.
###end p 9
###begin p 10
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 660 662 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 686 687 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 832 833 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 834 835 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 893 895 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 1106 1107 1103 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
Defective negative selection caused by weak interactions between self-peptides and major histocompatibility complex (MHC) molecules has been proposed as a mechanism that may contribute to autoimmunity. We have been interested in examining the relationship between peptide-MHC interactions and T-cell autoreactivity for disease-relevant antigens in autoimmune diabetes. In the case of the nonobese diabetic (NOD) mouse, the class II MHC molecule, I-Ag7, has been shown to be a weak peptide binder (1). While examining the CD4 T-cell response to peptides derived from the insulin beta-chain in the NOD mouse, we were struck by its low binding affinity to the I-Ag7 class II MHC molecule (2). Many of the spontaneous T-cells that were identified reacted to a segment previously identified as a focus for spontaneous T-cell reactivity (3-6). Such a peptide apparently bound in two registers to I-Ag7, but binding was in the low micromolar range and showed a fast dissociation rate. Many of the amino acids in the peptide affected both binding and T-cell recognition, implying a very loose peptide-MHC complex (2).
###end p 10
###begin p 11
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
The relationship of low affinity of a peptide to an MHC molecule and autoimmune reactivity has also been noted in the encephalitogenic peptide from myelin basic protein (7,8). This has led to the speculation that low-affinity peptides may not be conducive to the normal mechanisms in the thymus that control autoreactivity. A study by McNeil and Evavold noted that peptides with fast dissociation rates and poor binding to MHC molecules were ineffective at deleting thymocytes even though the same ligands were capable of eliciting proliferation of mature T-cells in the periphery (9). Similarly, in a tumor model system, low-affinity epitopes were shown to activate tumor-specific cytotoxic T-lymphocytes and could confer antitumor immunity on immunization (10). Lastly, a study by Roep and colleagues (11) that measured in vitro binding interactions of proinsulin epitopes to various HLA-DR molecules noted that DR alleles associated with protection from diabetes bound various proinsulin epitopes with a higher affinity when compared with DR molecules that predispose to type 1 diabetes.
###end p 11
###begin p 12
###xml 371 378 368 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 381 383 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 518 519 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 520 522 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
To further characterize the relationship between peptide-MHC binding strength and immune reactivity, we have examined other regions of the proinsulin molecule targeted by CD4 T-cells. The insulin molecule is derived from the processing of the prohormone proinsulin and is secreted from the pancreatic beta-cell with equimolar amounts of the connecting peptide C-peptide (Table 1) (12). We examined the proinsulin-1(47-64) (PI-1[47-64]) (SPGDLQTLALEVARQKRG) segment because reactivity to it had been found in NOD mice (5,13). These data extend our understanding of the role of proinsulin as an autoantigen in type 1 diabetes and demonstrate an inverse relationship between peptide-MHC affinity and T-cell autoreactivity against a defined beta-cell antigen epitope.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin p 14
###xml 19 21 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
NOD, NOD.scid, NOD.h4, B6.g7, and B10.BR mice were purchased from The Jackson Laboratories (Bar Harbor, ME). All mice were housed and cared for in accordance with the guidelines of the Washington University Committee for the Humane Care of Laboratory Animals and with National Institutes of Health guidelines on laboratory animal welfare.
###end p 14
###begin title 15
Peptides.
###end title 15
###begin p 16
Synthetic peptides were purchased from Biosynthesis (Lewisville, TX). All peptides were >95% pure, confirmed by high-performance liquid chromatography and mass spectrometry analysis.
###end p 16
###begin title 17
Peripancreatic lymph node assays.
###end title 17
###begin p 18
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 534 535 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 893 894 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 887 894 883 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Spleens, axillary and inguinal lymph nodes, and peripancreatic lymph nodes (PPLNs) were isolated from 10- to 16-week-old male and female NOD mice and dispersed into single-cell suspensions by passage through cell strainers. The splenocytes or lymph node cells (3-5 x 104/well) were subsequently cultured with irradiated NOD splenocytes (5 x 105/well) and 1-5 mumol/l peptide for 7 days in round-bottom 96-well plates in a final volume of 200 mul. On day 7, the cultures were re-stimulated with fresh irradiated NOD splenocytes (5 x 105/well), 25 units/ml interleukin (IL)-2, and 1-5 mumol/l peptide. T-cell-positive wells were tested days 14-17 with antigen-presenting cells (APCs) and 10 mumol/l peptide. Only data from cells with >200 counts per minute were considered, the stimulation index was calculated by dividing values for APCs plus peptide by APCs alone. The data presented in Fig. 2A were pooled from seven independent experiments. All tissue culturing was done in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS (DMEM 10% FCS).
###end p 18
###begin title 19
Primary T-cell lines.
###end title 19
###begin p 20
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 367 370 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3&#8211;4</sup>
###xml 437 438 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 640 642 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 163 166 <span type="species:ncbi:31658">CFA</span>
The anti-C-peptide (ACP) primary T-cell lines were generated by immunization of 8- to 10-week-old NOD mice with 10 nmol PI-1(47-64) in complete Freund's adjuvant (CFA). Immunized lymph nodes were harvested at day 7 and cultured at 5 x 105 cells/well in DMEM with 10% FCS and 1 mumol/l peptide. On day 7, and at 7- to 10-day intervals thereafter, the T-cells (1-2 x 103-4/w) were restimulated with fresh irradiated NOD splenocytes (5 x 105 cells/well), IL-2 (25 units/ml), and peptide (1 mumol/l). Hybridomas were generated from these primary lines by fusion to the BW5147 alpha-beta-thymoma partner cell line following standard techniques (14).
###end p 20
###begin title 21
T-cell assays.
###end title 21
###begin p 22
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 373 375 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 412 413 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 658 660 654 656 <sc xmlns:xlink="http://www.w3.org/1999/xlink">dl</sc>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
Primary T-cell proliferation assays were performed by incubation of T-cells (2 x 104/well) with irradiated NOD splenocytes (5 x 105/well) in the presence of peptide or dispersed mouse beta-cells. Primary T-cell proliferation assays were pulsed with thymidine (1 muCi/well) on day 2 and harvested day 3. T-cell hybridoma assays were performed with NOD splenocytes or the I-Ag7-expressing cell line, C3G7 (2.5 x 104/well), as APCs and supernatants were collected at 24 h for IL-2 quantitation by cytotoxic T-lymphocyte line assay. Fixation of the C3G7 cell line was performed by incubation in 1% paraformaldehyde for 15 min followed by incubation in 0.2 mol/l dl-lysine for 10 min and then washing three times in DMEM 10% FCS.
###end p 22
###begin title 23
Islet isolation.
###end title 23
###begin p 24
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Islets of Langerhans were isolated from mice of various ages and dispersed using standard techniques (15). The digestion of the pancreatic tissue was performed with type XI collagenase (Sigma, St. Louis, MO) without DNase.
###end p 24
###begin title 25
Enzyme-linked immunosorbent spot-forming cell analysis.
###end title 25
###begin p 26
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 56 59 <span type="species:ncbi:31658">CFA</span>
Mice were immunized with 10 nmol PI-1(47-64) peptide in CFA and lymph nodes were examined on day 7 by enzyme-linked immunosorbent spot-forming cell (ELISPOT) analysis for IL-2+ cells. Lymph node cells (1 x 106/well) were plated in triplicate on anti-IL-2 capture antibody-coated filter plates in the presence of 10 mumol/l antigen and developed 24 h later with anti-IL-2 detection antibodies (BD Biosciences, San Jose, CA). Plates were read by C.T.L. Cellular Technology and analyzed with ImmunoSpot 3.2 software.
###end p 26
###begin title 27
Peptide-binding assays.
###end title 27
###begin p 28
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 195 197 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 204 205 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 405 408 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
###xml 1025 1027 1005 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1092 1094 1072 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1111 1118 1091 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
Soluble I-Ag7 or I-Ak was produced using the recombinant baculovirus system as previously described (16). Peptide binding assays were done under acidic (pH 5.5) conditions. Briefly, 0.5-1 mug I-Ag7 or I-Ak/class II-associated invariant chain peptide was treated with 0.1 unit thrombin to cleave both the zipper tails and peptide linker (Novagen, Madison, WI) and simultaneously incubated with 0.125 pmol I125-radiolabeled mimotope reference peptide (GKKVATTVHAGYG) and increasing doses of unlabeled peptides in 200 mmol/l Tris(2-carboxyethyl) phosphine hydrochloride, 20 mmol/l MES, and 150 mmol/l sodium chloride. Binding reactions were incubated overnight at 25degreesC in 30-mul volumes. Complexes were purified from free peptide by gel filtration Bio-spin columns (Bio-Rad). The percentage of bound peptide was evaluated by gamma counting. Usually, approximately25-35% of input peptide was bound, whereas <0.5% of peptides nonspecifically passed through the Bio-spin columns. The half-maximal inhibitory concentration (IC50) value is very close to the binding equilibrium constant. The IC50 values shown in Table 2 are averages of three to five independent binding experiments.
###end p 28
###begin title 29
Biological dissociation rates.
###end title 29
###begin p 30
###xml 97 98 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 153 154 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
The C3G7 APC line was incubated with peptide (10 mumol/l) for 2 h and washed. ACP T-cells (2 x 104/well) were added to the APC-containing wells (2.5 x 104/well) cultures at time zero and at 4 and 8 h after washing. The supernatants were collected at 24 h, and IL-2 was measured by cytotoxic T-lymphocyte line assay.
###end p 30
###begin title 31
Adoptive T-cell transfer.
###end title 31
###begin p 32
Two of the three primary ACP T-cell lines were expanded in vitro and transferred into 8- to 12-week-old NOD.scid recipients by tail vein injection. Diabetes was defined by the measurement of blood sugars >250 mg/dl on two separate occasions. All recipients were followed for 30 weeks or up to disease onset.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
The PI-1(47-64) peptide bound weakly to I-Ag7.
###end title 34
###begin p 35
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 83 85 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 350 352 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 361 363 361 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 412 419 411 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 476 477 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 486 488 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 586 588 584 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 600 602 598 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 758 760 755 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 845 847 839 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 858 860 852 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 791 796 <span type="species:ncbi:10090">mouse</span>
Binding assays were done with soluble I-Ag7 and I-Ak and synthetic peptides. The IC50 value indicates the concentration of unlabeled peptide required to affect binding of a reference peptide to the class II molecules: the higher the value, the weaker the binding of the peptide to the MHC. The PI-1(47-64) and PI-2(49-66) peptides bound poorly to I-Ag7, with IC50 values of 98.9 and 135.9 mumol/l, respectively (Table 2). In contrast, these peptides bound more strongly to I-Ak, with IC50 values of 4.8 and 2.1 mumol/l, respectively. The PI-1(49-61) peptide bound slightly better to I-Ag7, with an IC50 of 20 mumol/l, perhaps due to the loss of the positively charged P62Lys, which is likely disfavored at the carboxy-end of the peptide-binding groove of I-Ag7. As a point of reference, the mouse insulin-2 beta-chain (9-23) peptide bound to I-Ag7 with an IC50 of 3 mumol/l.
###end p 35
###begin title 36
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
Reactivity to PI-1(47-64) is I-Ag7 dependent.
###end title 36
###begin p 37
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 331 333 331 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 399 406 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 436 438 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k+</sup>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 461 468 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 699 701 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 810 812 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 899 901 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 935 937 923 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">Mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
The role played by the MHC class II molecule, I-Ag7, and background genes in autoreactivity to C-peptide was examined by characterizing the T-cell responses in NOD, NOD.h4, B6.g7, and B10.BR mice. Mice were immunized with the PI-1(47-64) peptide, and lymph nodes were examined on day 7 by ELISPOT analysis for IL-2+ cells. Both I-Ag7-containing strains, NOD and B6.g7, had peptide-reactive T-cells (Fig. 1A and C), compared with the I-Ak+ strains that did not (Fig. 1B and D). The frequency of PI-1(47-64)-reactive cells detected under these conditions was low: approximately1/30,000 in the NOD mice and 1/50,000 in the B6.g7 mice. However, PI-1(47-64)-specific T-cells were not detected in the NOD.h4 and B10.BR mice. The T-cell reactivity against PI-1(47-64) present in the NOD and B6.g7 mice was clearly I-Ag7 restricted as evidenced by inhibition with MHC class II-blocking antibody, AG.2.42.7 (17). These data demonstrate that I-Ag7 alone is necessary and sufficient for the generation of PI-1(47-64) T-cells independent of other background genes.
###end p 37
###begin title 38
PPLNs harbor C-peptide-reactive T-cells.
###end title 38
###begin p 39
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 840 841 840 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 1526 1530 <span type="species:ncbi:10090">mice</span>
Given the central importance of the PPLNs in the priming of diabetogenic T-cells, we began by examining the PPLNs of pre-diabetic mice for the presence of T-cells specific for the PI-1(47-64) peptide. Like others (5,18), we did not detect reactivity to proinsulin peptides in primary proliferation assays with PPLNs or spleens from 10- to 16-week-old NOD mice (data not shown). Given this difficulty in detecting primary T-cell responses, we expanded PPLN T-cells, in addition to T-cells from the spleen and peripheral lymph nodes, for 2 weeks in vitro with the PI-1(47-64) peptide, and then tested all T-cells in the expanded cultures for peptide reactivity. T-cells specific for the PI-1(47-64) peptide were identified in the PPLNs from 10- to 16-week-old mice but were not found in the spleen or axillary and inguinal lymph nodes (Fig. 2A and B). Five of 246 expanded T-cell lines from the PPLNs reacted with the PI-1(47-64) peptide (stimulation index >5). In contrast, no PI-1(47-64)-reactive T-cells were detected from the 454 T-cell lines expanded from the spleen or axillary and inguinal lymph nodes. The presence of C-peptide-reactive T-cells in the PPLNs was in agreement with previous data that indicated these nodes as the site for priming of diabetogenic T-cells (19-21). Moreover, this finding also suggested a possible role for these T-cells in the early pathogenesis of the disease. To further characterize the biology of C-peptide-reactive T-cells, we first generated T-cell lines by immunization of young NOD mice.
###end p 39
###begin title 40
###xml 4 8 <span type="species:ncbi:10090">mice</span>
NOD mice lack tolerance to the PI-1(47-64) self-peptide.
###end title 40
###begin p 41
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 140 133 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 48 51 <span type="species:ncbi:31658">CFA</span>
Mice were immunized with PI-1(47-64) peptide in CFA, and several primary CD4+ T-cell lines were generated, including the ACP 2 line (Fig. 3A). All lines demonstrated similar reactivity in vitro; they were maximally stimulated by the PI(47-64) peptide from proinsulin-1 and also reactive with the PI(49-66) peptide from proinsulin-2. The T-cell lines also recognized the PI-1(49-61) and the PI-2(51-63) segments, which differ only by one residue (Arg for PI-1 at position 60 and Gln for PI-2 at position 62). The T-cell lines were stimulated by the full-length C-peptides from proinsulin 1 and 2, although less than they were by the PI-1(47-64) peptide.
###end p 41
###begin p 42
###xml 387 388 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 381 388 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 571 572 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 565 572 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
To determine whether the ACP T-cell lines were reactive with the naturally processed and presented forms of the proinsulin epitope, T-cells were tested for reactivity with freshly isolated mouse beta-cells. All three primary ACP lines, including ACP 2, reacted to dispersed mouse beta-cells from young NOD mice (4-6 weeks of age) and beta-cells from other strains such as 129/Svj (Fig. 3B). Furthermore, the ACP T-cells reacted to dispersed islets isolated from 5-month-old NOD mice, demonstrating that APCs from the islet infiltrate present the C-peptide epitope (Fig. 3C).
###end p 42
###begin title 43
Minimal epitope mapping and antigen processing requirements for C-peptide-reactive T-cells.
###end title 43
###begin p 44
###xml 98 104 98 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 978 979 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
Analysis of ACP T-cell hybridomas showed heterogeneity in their reactivity to truncated peptides (Fig. 4A; Table 3). The likely minimal T-cell epitope spanned the PI-1(51-61) sequence (LQTLALEVARQ) because loss of the P51Leu resulted in a noticeable decrease in T-cell activation for all hybridomas examined (Fig. 4A; Table 3). Some T-cells, such as ACP2.1, responded well to the PI-1(49-60) peptide lacking the P61Gln, whereas others did not (see ACP1.28), indicating variable requirements for carboxy-terminal residues. Identification of the nonamer canonical core within the PI-1(51-61) segment could not be determined by T-cell reactivity, and all T-cells tested (0 of 8) with the three possible nonamers spanning the PI-1(51-61) peptide were negative (51-59, LQTLALEVA; 52-60, QTLALEVAR; and 53-61, TLALEVARQ). These results may indicate a need for amino- or carboxy-flanking residues that serve as T-cell receptor contacts, as was seen with the beta-chain (9-23) epitope (2), loss of MHC binding affinity with the truncated peptides, or both.
###end p 44
###begin p 45
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 302 309 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
To assess the requirements for antigen processing of the C-peptide T-cell epitopes, T-cells were tested for reactivity with synthetic peptides presented by fixed APCs. We found that ACP T-cell hybridomas were stimulated by fixed APCs presenting the PI-1(47-64), PI-1(49-61), and full-length C-peptide (Fig. 4B), indicating that all three peptides, even the full-length C-peptide-1 29-mer, could form recognizable complexes without the need for further processing.
###end p 45
###begin p 46
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
We next examined the stability of the peptide-MHC complexes formed by PI-1(47-64) and I-Ag7 by functional experiments in which T-cells were applied to antigen-pulsed and washed APCs over an 8-h time course (Fig. 4C). The antigen-pulsed APCs quickly lost their ability to stimulate C-peptide-reactive T-cells. The T-cell response, for both PI-1(47-64)-and C-peptide-1-pulsed APCs, was reduced to 50% of its maximal value in 3 h, indicating that the C-peptide-MHC complexes disassociated rapidly.
###end p 46
###begin title 47
C-peptide-reactive T-cells induce diabetes.
###end title 47
###begin p 48
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 1140 1141 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1134 1141 1131 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 863 878 <span type="species:ncbi:10090">transgenic mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
The pathogenicity of the ACP primary T-cell lines was assessed by adoptive transfer into NOD.scid recipient mice. Three separate transfer experiments were performed: group 1 (n = 8) received 9.4 x 106 ACP no. 1 T-cells; group 2 (n = 4) received 17 x 106 ACP no. 2 T-cells; and group 3 (n = 4) received three infusions of ACP nos. 1 and 2 T-cells. The incidence of diabetes was 50% for all groups; group 1 (4 of 8) by 20 weeks after transfer, group 2 (2 of 4) at 10 and 20 weeks after transfer, and group 3 (2 of 4) at 20 and 22 weeks after transfer (Fig. 5A). The induction of diabetes in 8/16 NOD.scid mice, which never naturally develop diabetes, indicated that the ACP T-cells were pathogenic in the adoptive transfer model. Although the kinetics of disease induction in these experiments is less than some observed with activated T-cells from T-cell receptor transgenic mice, e.g., BDC2.5 the incidence is similar to the spontaneous incidence seen in wild-type NOD mice. Furthermore, all recipient mice, including those that were not overtly hyperglycemic at 30 weeks, had severe destructive insulitis and loss of beta-cell mass (Fig. 5B).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 319 320 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 536 537 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
The main findings from these studies are 1) binding of the PI-1(47-64) and PI-1(49-61) peptides to I-Ag7 is incredibly poor, and the peptide-MHC complexes are short-lived; 2) I-Ag7 plays a central role in the generation of the ACP T-cell repertoire, in that autoreactivity was found to strains bearing I-Ag7 but not I-Ak molecules; 3) C-peptide-reactive T-cells are found in the PPLNs of pre-diabetic NOD mice; 4) ACP T-cells are reactive with mouse beta-cells and respond to full-length C-peptide presented by live and fixed APCs; and 5) despite this weak peptide-MHC interaction, C-peptide-reactive T-cells are capable of causing diabetes in an adoptive transfer model.
###end p 50
###begin p 51
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 814 815 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 808 815 808 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 889 890 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 883 890 883 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
Our data confirm and extend the observations of other groups that have identified the C-peptide region of proinsulin as a CD4+ T-cell target in the NOD mouse (5,13,22,23). The recovery of C-peptide-reactive T-cells from the PPLNs and not from other locations suggests that these T-cells may encounter their antigen in this critically important site of diabetogenic T-cell priming (19-21,24). Intra-islet APCs, most likely dendritic cells, must encounter large amounts of C-peptide in the islets and may traffic to the PPLNs, where they could prime and activate naive C-peptide-reactive T-cells. Alternatively, lymphatic drainage of the pancreas might deliver high concentrations of C-peptide to the PPLNs, allowing uptake and presentation by nodal dwelling APCs. The islets readily provided antigen to APCs (Fig. 3B), and APCs recovered from insulitic islets stimulated the T-cells (Fig. 3C). In either case, it is not difficult to imagine a scenario in which PPLNs are exposed to large amounts of C-peptide, which would be required for activation of the T-cells by these very weak MHC-binding peptides. Although C-peptide circulates, its concentration in blood (2-5 nmol/l) would not be sufficient for either activation or regulation in APCs at peripheral sites.
###end p 51
###begin p 52
###xml 376 378 376 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 690 691 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 692 693 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 760 761 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 791 792 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 793 795 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
Why are C-peptide-reactive T-cells not deleted in the thymus? Weak MHC-binding peptides may well be the best at fostering autoimmunity, in great part by avoiding negative selection in the thymus or by failure of regulatory mechanisms, although other factors are likely to play a role. The PI-1(47-64) epitope represents a striking example of a very poor binding MHC ligand, IC50 values approximately100 mumol/l, that gives rise to T-cells capable of causing diabetes in adoptive transfer experiments. The relationship between poor peptide-MHC binding and the fostering of an autoimmune, pathogenic T-cell repertoire has been suggested in studies on experimental allergic encephalomyelitis (7,8) and in our recent work on the insulin beta-chain (9-23) epitope (2) and in other model systems (9-11).
###end p 52
###begin p 53
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7+</sup>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k+</sup>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7+</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k+</sup>
###xml 261 263 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 363 369 363 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 681 683 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 767 769 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 985 987 985 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 1108 1110 1108 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 1302 1306 <span type="species:ncbi:10090">mice</span>
###xml 1383 1387 <span type="species:ncbi:10090">mice</span>
The obligatory role for the diabetogenic I-Ag7 molecule in eliciting C-peptide-reactive CD4 T-cells remains a key issue. Our results with the four mouse strains NOD (I-Ag7+), NOD.h4 (I-Ak+), B6.g7 (I-Ag7+), and B10.BR (I-Ak+) demonstrated that expression of I-Ag7, independent of the genetic background, was sufficient to generate C-peptide-reactive CD4 T-cells (Fig. 1). This is in agreement with previous data from Kanagawa et al. (25) and Ridgway et al. (26), indicating that the expression of I-Ag7 in different strains of mice allowed escape of autoreactive T-cells. A more recent study from Stratmann et al. (27) used MHC tetramers to trace islet-reactive CD4+ T-cells in I-Ag7-expressing mice of different genetic backgrounds. Here again, the expression of I-Ag7 in different strains selected for tetramer-reactive CD4+ T-cells. The NOD strain has also been shown to be susceptible to other autoimmune diseases (28-31). Taken together, these data point to a central role for I-Ag7 in selection (or escape) of autoreactive T-cells. We believe that the explanation lies in the structural features of I-Ag7, characterized by an overall low peptide-binding affinity and instability (32), in addition to other susceptibility genes. These findings do not lessen the importance of other factors in NOD mice that play a role in the loss of self tolerance (33-35). The fact that B6.g7 mice do not develop diabetes highlights the need of both MHC- and non-MHC-encoded susceptibility genes.
###end p 53
###begin p 54
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
A second important factor in the lack of T-cell tolerance may be specific to the insulin molecule. It may be that the peptide-MHC complexes formed in the thymus do not recapitulate the complexes that appear in the periphery. The deleting complexes are presumably formed by the traditional processing and presentation of proinsulin peptides in thymic medullary epithelial cells. Here, peptides are selected by the biological and physical forces that govern peptide presentation by I-Ag7 molecules in thymic cells and are not the same as events that might occur in the periphery. Although proinsulin is clearly expressed in the thymus (36,37), perhaps largely under the control of the autoimmune regulator transcription factor (38), there is no evidence of the expression of the prohormone processing machinery, such as the prohormone convertases 1 and 2, which would be required to generate the actual C-peptide fragment that is secreted by the beta-cell. The absence of tolerance to C-peptide, as it is presented in the pancreas, may be explained, in a sense, by the lack of a secretory apparatus in the thymus.
###end p 54
###begin p 55
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
###xml 723 728 <span type="species:ncbi:9606">human</span>
The data presented here extend our understanding of the role of proinsulin as an autoantigen and again seem to illustrate an inverse relationship between weak peptide-MHC binding and T-cell autoimmune pathogenicity. The degree to which C-peptide-reactive T-cells contribute to disease pathogenesis in the NOD mouse cannot be determined with certainty. The T-cells were pathogenic in circumstances of adoptive transfer, and they represent one set of the many proinsulin-reactive T-cells that seem to play a key role in the development of autoimmune diabetes. The identification of T-cell reactivity against C-peptide epitopes in type 1 diabetic patients suggests that C-peptide might also be an important autoantigen in the human disease (39-42).
###end p 55
###begin p 56
This work was supported by grants from the Barnes-Jewish Hospital Foundation, the National Institutes of Health (DK-067199 and DK-020279), and the Kilo Diabetes and Vascular Research Foundation.
###end p 56
###begin p 57
We thank Shirley Petzold for technical assistance.
###end p 57
###begin title 58
REFERENCES
###end title 58
###begin p 59
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k+</sup>
###xml 181 183 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 437 439 425 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h4</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
The ACP T-cell repertoire in NOD mice is I-Ag7 dependent. Both I-Ag7-containing strains, NOD and B6.g7, had peptide-reactive T-cells (A and C), compared with the I-Ak+ strains, NOD.h4 and B10.BR, that did not (B and D). The frequency of PI-1(47-64)-reactive cells detected under these conditions was approximately1/30,000 in the NOD mice and 1/50,000 in the B6.g7 mice. However, PI-1(47-64)-specific T-cells were not detected in the NOD.h4 and B10.BR mice. The T-cell response to PI-1(47-64) in NOD and B6.g7 mice was MHC class II restricted as evidenced by inhibition with the MHC class II-blocking antibody, AG.2.42.7. Data presented are representative of three independent experiments.
###end p 59
###begin p 60
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
PPLNs contain T-cells reactive with PI-1(47-64). A: T-cells from the PPLNs of NOD mice from 10-16 weeks of age contain PI-1(47-64)-reactive T-cells. Five of 246 expanded T-cell lines from the PPLNs reacted with the SPGDLQTLALEVARQKRG peptide with a stimulation index (SI) >5. In contrast, 0 of 454 T-cell lines expanded from the spleen or axillary and inguinal lymph nodes were stimulated by the PI-1(47-64) peptide. B: Data from one representative experiment in which 41 T-cell lines from the PPLNs were tested for reactivity with the PI-1(47-64) peptide.
###end p 60
###begin p 61
###xml 68 69 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 394 395 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 660 661 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
Primary anti-PI-1(47-64) T-cell lines are reactive with beta-cells. A: Three primary anti-PI-1(47-64) T-cell lines were generated by immunization of young NOD mice. One such line, ACP no. 2, recognized the PI-1(47-64) peptide in addition to the PI-1(49-61) segment and full-length C-peptide-1. The ACP no. 2 T-cell line recognized peptides from the PI-2 sequence, although not as well as PI-1. B: The ACP no. 2 T-cell line responded to freshly isolated beta-cells from 4- to 6-week-old NOD mice. In both peptide and beta-cell assays, irradiated NOD splenocytes were used as APCs and cultures were pulsed with labeled thymidine on day 2 and harvested on day 3. C: ACP no. 1 reacted to dispersed islets from 5-month-old NOD mice in the absence of exogenous APCs.
###end p 61
###begin p 62
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 500 501 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 822 823 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1070 1071 1069 1070 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1076 1077 1075 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 1154 1155 1153 1154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
ACP T-cells respond to PI-1(49-61), and full-length C-peptide presented by fixed APCs and the peptide-MHC (pMHC) complexes disassociate rapidly. A: The ACP1.28 T-cell responds well to PI-1(49-61):GDLQTLALEVARQ; however, reactivity was abolished with the loss of the P51Leu or the P61Gln. The ACP2.1 T-cell, in contrast, appeared to tolerate truncations of the flanks and recognized PI-1(49-60):GDLQTLALEVAR rather well and responded weakly to both PI-1(52-61):QTLALEVARQ and PI-1(49-59):GDLQTLALEVA. B: Both ACP1.28 and ACP2.1 responded strongly to fixed APCs pulsed with peptide, indicating that further processing of the peptide was not required. This was true for the PI-1(47-64) and PI-1(49-61) epitopes and the full-length C-peptide-1 molecule (peptide concentration 30 mumol/l; experiments performed in triplicate). C: The stability of the pMHC complexes formed from PI-1(47-64) or C-peptide-1 was examined by adding T-cells to antigen-pulsed and washed APCs over an 8-h time course. The percent maximal response was determined by dividing the T-cell response at T4 or T8, in counts per minute by the value achieved when the T-cells were added at T0. APCs pulsed with either PI-1(47-64) or C-peptide-1 lost 50% of their ability to maximally stimulate T-cells in 3 h, indicating that the pMHC complexes disassociated rapidly on the surface of the APCs.
###end p 62
###begin p 63
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 221 248 221 248 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
ACP T-cells transferred disease into recipient NOD.scid mice and caused severe insulitis. A: Adoptive transfer of ACP T-cells into NOD.scid recipient mice induced diabetes in 50% (8 of 16) by 22 weeks after transfer. See research design and methods for details. B: Histology of islets from all recipient mice, diabetic and normoglycemic, showed severe, destructive insulitis. The islet histology shown in this figure was taken from a nondiabetic recipient mouse at 30 weeks after transfer.
###end p 63
###begin p 64
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
Human and murine proinsulin sequences
###end p 64
###begin p 65
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
The sequences of the human, mouse-1, and mouse-2 proinsulin molecules are shown. The amino acid residues in bold are cleaved off during the physiological processing of the prohormone, and C-peptide is secreted in equimolar amount with the mature insulin heterodimer. The amino acid residue numbering refers to the mouse proinsulin-1 sequence, and the PI-1(47-64) segment is underlined.
###end p 65
###begin p 66
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
Binding to I-Ag7
###end p 66
###begin p 67
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 113 115 113 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 209 211 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 228 230 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 388 415 386 413 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
This panel shows the binding analysis of synthetic peptides to soluble I-Ag7 and I-Ak. Binding is expressed by IC50 values (mumol/l). The mime peptide is a synthetic reference peptide that has been used in I-Ag7 binding assays (16). The binding of mouse insulin-2 B:(9-23) (3 mumol/l) peptide is presented as a point of reference. Binding studies were performed at pH 5.5 as described in research design and methods.
###end p 67
###begin p 68
ACP T-cell half-maximal stimulatory concentration values
###end p 68
###begin p 69
Values shown are concentrations of peptide required to half-maximally stimulate a given T-cell (mumol/l; -, none detected). Values are averages of two to five independent experiments.
###end p 69

